Click here to view the programme of Session 3a

Update on biomarker in gastric cancer

Chairs :
Heike Grabsch (pathologist, Maastricht UMC, The Netherlands)  and
Ryoji Kushima, Shiga University of Medical Science, Seta, Otsu, Shiga, Japan

10.45  Biomarkers in routine H&E stained sections
Luca Saragoni, pathologist, Universita di Bologna, Italy

11:05  Molecular biomarkers
Patrick Tan, Translational scientist, Duke-NUS Medical School, Singapore

11:25  Circulating DNA
Nicole van Grieken, pathologist, Amsterdam UMC, The Netherlands

11:45 Accepted oral abstract 02.2.4: Host Tissue Factors Predict Immune Surveillance and Clinical Outcomes in Gastric Cancer
Emily Stroobant, Resident, Memorial Sloan Kettering Cancer Center, United States

11:55 Accepted oral abstract 02.2.5: Unraveling the Role of FGFBP2+NK Cells as Predictive Biomarkers in Gastric Adenocarcinoma Immunotherapy
Hongda Pan, Surgeon, Fudan University Shanghai Cancer Center, China

12:05 Accepted oral abstract 02.2.6: B cells in gastric cancer: spatially resolved profiles and associations with chemotherapy response
Joseph Zhao, Resident, National University Cancer Institute, Singapore

12:15  End of session

  • Parallel session 1

    Session 3a: Pathology / Translational research

    Date: 09 May 2025Time: 10:45 - 12:15 CET